Rebecca A Fuldner

Title: The Innovative Contributions of Rebecca A Fuldner

Introduction

Rebecca A Fuldner is a prominent inventor based in Barnesville, MD (US). She has made significant contributions to the field of genetic research, particularly in the area of DNA repair proteins. With a total of 10 patents to her name, her work has implications for cancer diagnosis and treatment.

Latest Patents

Fuldner's latest patents focus on human DNA mismatch repair proteins. The first patent discloses three human DNA repair proteins and the DNA (RNA) encoding such proteins. These proteins can be produced using recombinant DNA techniques. One of the proteins, hMLH1, has been mapped on chromosome 3. The polynucleotide sequences of these DNA repair proteins may be utilized for diagnosing hereditary susceptibility to cancer. The second patent also addresses human DNA mismatch repair proteins, detailing a procedure for producing these proteins through recombinant techniques. In this patent, hMLH1 is mapped to chromosome 3, hMLH2 to chromosome 2, and hMLH3 to chromosome 7. The sequences of these proteins hold potential for therapeutic and diagnostic treatments related to hereditary cancer susceptibility.

Career Highlights

Throughout her career, Fuldner has worked with notable organizations, including Human Genome Sciences, Inc. Her innovative research has positioned her as a key figure in the field of genetics.

Collaborations

Fuldner has collaborated with esteemed colleagues such as Mark D Adams and Craig A Rosen, contributing to the advancement of genetic research.

Conclusion

Rebecca A Fuldner's contributions to the field of DNA repair proteins highlight her innovative spirit and dedication to advancing genetic research. Her patents not only enhance our understanding of hereditary cancer susceptibility but also pave the way for future therapeutic developments.